# Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps

> **NCT00724685** · PHASE4 · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 34 (actual)

## Conditions studied

- Post Operative Analgesia

## Interventions

- **DRUG:** Naropeine (Ropivacaine)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00724685
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724685, "Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00724685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*